Delivery Order SPE2DB24D1107-SPE2DB25FZEE3
Award Date
1/23/25
Potential Completion Date
1/24/25
Potential Value
$2.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $3,390.27, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LANTUS 100 UNIT/ML VIAL 10ML, a specialty medication, to support military healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,063.88, is for the delivery of Lantus 100 unit/mL vial, a medication used to treat diabetes. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,278.10, is a delivery order for the supply of Lantus 100 unit/mL vial 10mL, a diabetes medication. The contract has an ultimate completion date of April 21, 2025 and is a firm fixed-price contract. This award is not associated with a set-aside program and is part of a larger Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,155.77 delivery order contract is for the supply of Lantus 100 unit/ml vial (10 ml), a specialty medication used for the treatment of diabetes. The contract has an ultimate completion date of May 31, 2023 and is a firm fixed-price agreement. This award is part of a larger Indefinite Delivery Contract (IDC) held...
This federal contract award is from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,897.50 firm fixed-price delivery order is for the supply of Lantus 100 unit/mL vial, a prescription insulin medication. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, valued at $1,200.70, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of LANTUS 100 UNIT/ML VIAL 10ML, a medication used to treat diabetes. The contract has a firm fixed price and an ultimate completion date of July 3, 2023. While the original solicitation is not provided, the award indicates that the contract is not...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $1,001.43, is for the delivery of Lantus 100 unit/mL vial, 10 mL, a specialty medication used for the treatment of diabetes. The contract is a firm fixed-price delivery order with an ultimate completion date of April 3, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,236.06 delivery order contract is for the supply of LANTUS 100 UNIT/ML VIAL 10ML, a prescription medication used for the treatment of diabetes. The contract has a firm fixed price pricing type and does not have any set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999...
This is a federal contract award made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,047.37, is for the delivery of LANTUS 100 UNIT/ML VIAL 10ML, a prescription medication used to treat diabetes. The award is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,856.40 contract is a Firm Fixed Price Delivery Order for Lantus 100 Unit/ML Vial 10ML, a specialty medication used for treating diabetes. The contract has an ultimate completion date of November 20, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...